McDermott Will & Schulte has advised Servier on the acquisition of BN104 from BioNova.Servier, an international, independent pharmaceutical group governed by a foundation, has completed the…
Servier Acquires Menin Inhibitor BN104 from BioNova


McDermott Will & Schulte has advised Servier on the acquisition of BN104 from BioNova.Servier, an international, independent pharmaceutical group governed by a foundation, has completed the…
You must be a Standard 1 Year member to access this content.
…
You must be a Standard 1 Year member to access this content.